Menu
GeneBe

11-63370070-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_080866.3(SLC22A9):ā€‹c.14A>Gā€‹(p.Asp5Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000701 in 1,611,552 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000039 ( 0 hom., cov: 32)
Exomes š‘“: 0.000073 ( 0 hom. )

Consequence

SLC22A9
NM_080866.3 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.66
Variant links:
Genes affected
SLC22A9 (HGNC:16261): (solute carrier family 22 member 9) Enables anion:anion antiporter activity; short-chain fatty acid transmembrane transporter activity; and sodium-independent organic anion transmembrane transporter activity. Involved in hormone transport; short-chain fatty acid import; and sodium-independent organic anion transport. Located in basolateral plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.058416158).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SLC22A9NM_080866.3 linkuse as main transcriptc.14A>G p.Asp5Gly missense_variant 1/10 ENST00000279178.4
SLC22A9XM_017017159.3 linkuse as main transcriptc.14A>G p.Asp5Gly missense_variant 1/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SLC22A9ENST00000279178.4 linkuse as main transcriptc.14A>G p.Asp5Gly missense_variant 1/101 NM_080866.3 P1Q8IVM8-1
SLC22A9ENST00000536333.5 linkuse as main transcriptc.14A>G p.Asp5Gly missense_variant, NMD_transcript_variant 1/71 Q8IVM8-2

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
152046
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000643
AC:
16
AN:
249004
Hom.:
0
AF XY:
0.0000521
AC XY:
7
AN XY:
134456
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000711
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000801
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000733
AC:
107
AN:
1459506
Hom.:
0
Cov.:
31
AF XY:
0.0000689
AC XY:
50
AN XY:
725926
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000579
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000756
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
152046
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74262
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000181
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000659
AC:
8
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 23, 2023The c.14A>G (p.D5G) alteration is located in exon 1 (coding exon 1) of the SLC22A9 gene. This alteration results from a A to G substitution at nucleotide position 14, causing the aspartic acid (D) at amino acid position 5 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
10
DANN
Benign
0.95
DEOGEN2
Benign
0.12
T
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.85
FATHMM_MKL
Benign
0.18
N
LIST_S2
Benign
0.34
T
M_CAP
Benign
0.0029
T
MetaRNN
Benign
0.058
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Pathogenic
3.1
M
MutationTaster
Benign
1.0
N;N
PrimateAI
Uncertain
0.56
T
PROVEAN
Uncertain
-4.1
D
REVEL
Benign
0.069
Sift
Benign
0.043
D
Sift4G
Uncertain
0.0080
D
Polyphen
0.021
B
Vest4
0.11
MutPred
0.55
Gain of catalytic residue at D5 (P = 0.0581);
MVP
0.18
MPC
0.014
ClinPred
0.52
D
GERP RS
1.0
Varity_R
0.12
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs765887719; hg19: chr11-63137542; API